SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Microcap Potential Homeruns--Credible, and Reporting -- Ignore unavailable to you. Want to Upgrade?


To: Ted M who wrote (491)2/12/2010 1:45:57 PM
From: rogerover  Read Replies (1) | Respond to of 1056
 
How about CTDH? Profitable already -- market cap under $2 million -- huge wildcards.



To: Ted M who wrote (491)2/12/2010 5:56:39 PM
From: John F. Poteraske  Respond to of 1056
 
Ted-I agree with quite a few on that list.

VSCP
NEIK
MKRS

I'd like to add GNVC to list :)



To: Ted M who wrote (491)2/12/2010 6:11:10 PM
From: caly  Read Replies (2) | Respond to of 1056
 
I'm on board with...

VSCP -- medical imaging
NEIK -- defense support
NADVF -- cotton replacement

and John's mentioned...

GNVC -- biopharma

The latter took hit on the announcement of an offering and provided a nice entry point.

SNMX just announced an offering too, and took a major hit today. May also be a nice buying opp. They are the scourge of food-watch people, though, and are controversial.

SNMX -- flavor ingredients utilizing taste receptor technologies



To: Ted M who wrote (491)2/13/2010 2:43:13 PM
From: Ernest K Brandt  Respond to of 1056
 
Ted, thanks for posting the list. I own all of them except for HFFI VKNG EVTN and NADVF. I will take a lookk at them. Ernie



To: Ted M who wrote (491)2/23/2010 3:29:43 PM
From: Ted M  Read Replies (1) | Respond to of 1056
 
Logical comments from a poster on yahoo regarding VKNG:

"Interesting comments (full paragraph and link below) regarding the prototype delivered in Q4 to a "robotic surgical company" (almost certainly ISRG) in the recently filed VKNG 10k.

I have pointed out in the past a number of facts, and some opinions that people on this board have taken to be bashing. One fact was that the revenue from this design and development contract was nearly at an end and in fact ended with the delivery of the prototype. This is confirmed in the text below.

I had also pointed out that the statements from VKNG management last qtr had been very vague with regards to their chances of getting a follow on contract to actually manufacture the resulting product. I suggested that VKNG's chances were not very good because ISRG did not appear to be using VKNG to manufacture their current generation 3DHD daVinci vision system. Good news for VKNG longs. The new comments while hardly a guarantee are much more hopeful.

"It is the parties’ (ISRG)stated intentions that this development agreement will lead to a multi-year supply agreement whereby we manufacture and supply products to the other party."

In my mind these much more pointed comments significantly increase the likelihood that they will get some ongoing business out of this. Now the question is, if they get that contract how big will it be and when will it start? It is my belief that this is related to the integration of florescent imaging that ISRG has announced they plan to integrate into their current 3DHD Vision System. This is a technology which they have licensed from a company called Novadaq and which is expected to be launched some time later this year. One big unknown is whether ISRG will offer this as an option or whether they will make it a standard part of their daVinci surgical system. The first scenario would result in lower volumes and slower adoption where as the second scenario would result in several hundred units per year very quickly. In either case the contract is likely to be awarded fairly soon if the product is due to launch later this year. It is unclear how much detail we would get when and if siuch an announcement is made.

- - - - -

Here's the relevant paragraph from the recent VKNG 10k

In the fourth quarter of 2009 we also completed development work of a 3DHD visualization system for a robotic surgical company under a development contract that provided us approximately $800,000 of total revenue beginning in late 2007 and ending in 2009. It is the parties’ stated intentions that this development agreement will lead to a multi-year supply agreement whereby we manufacture and supply products to the other party. No assurance can be made that we will enter into a supply agreement as a result of this engineering contract.

Here's a link to the full filing
sec.gov "



To: Ted M who wrote (491)3/16/2010 10:17:58 AM
From: Ted M  Read Replies (1) | Respond to of 1056
 
ZAGG, good year, maybe turned corner now:

SALT LAKE CITY--(BUSINESS WIRE)--ZAGG Inc. (NASDAQ: ZAGG) (www.ZAGG.com), a leading producer of mobile electronics accessories including the popular invisibleSHIELD™ and ZAGGaudio™ brands, today announced financial results for the fourth quarter and full year ended December 31, 2009.

Financial Results

Revenue for the fourth quarter was $11.3 million, a 50% increase from the fourth quarter of 2008, and a 16% sequential increase as compared to the third quarter of 2009. Revenue for the full year was $38.4 million, a 94% increase from $19.8 million in 2008.

Gross profit for the fourth quarter was $6.1 million, or 54% of sales, compared to $3.8 million, or 52% of sales in the fourth quarter of 2008. Gross profit for the full year was $22.1 million, or 58% of sales, compared to $13.2 million, or 67% of sales in 2008.

Net income for the fourth quarter was $0.3 million or $0.01 per share as compared to net income of $1.1 million or $0.06 per share in the fourth quarter of 2008. Net income for the full year was $3.4 million or $0.15 per share as compared to net income of $2.1 million or $0.11 per share in the prior year.

During the fourth quarter, the Company took one-time charges of $1.2 million or $0.05 per share related to the following items:

* Notes receivable and related interest receivable of $0.7 million or $0.03 per share
* Reserves against accounts receivable of $0.4 million or $0.02 per share
* Inventory obsolescence reserves of $0.1 million

“We are very pleased with our record revenue growth again for 2009, and our continued acceptance in the retail channel with our flagship product, the invisibleSHIELD,” said Robert G. Pedersen II, President and CEO of ZAGG. “The Electronic Mobile Device accessories market is a huge opportunity for ZAGG, and we have made a firm entry into this sector with products that will take market share and serve the consumers’ needs.”

Business highlights

During the fourth quarter, we announced new distribution into Cricket’s retail stores, as well as a distribution agreement announced with T-Mobile in Germany for the invisibleSHIELD. T-Mobile is the exclusive seller of the Apple iPhone in Germany.

An important milestone during the quarter was our NASDAQ listing in early November.

As a part of our strategy to broaden our product offering, ZAGG released a new ZAGG audio line, ZAGGbuds and ZAGGsmartbuds in the fourth quarter. We also launched ZAGGskins, customizable invisibleSHIELD protection for mobile devices. The products were launched on the ZAGG website, and we are seeing good sell-through on both lines.

ZAGG continues to make progress with two initiatives announced before year-end: the ZAGGbox media center and HzO, a water blocking system for personal electronics that ZAGG has retained the exclusive marketing rights to; both of which are important to the long-term strategy of the company.

Adjusted EBITDA

ZAGG considers earnings before other income or expense; income tax provision or benefit; impairment losses; depreciation and amortization; and share-based compensation expense related to stock and stock options (“Adjusted EBITDA”) to be important financial indicators of the Company’s operational strength and the performance of its business. These results should be considered in addition to results prepared in accordance with generally accepted accounting principles (“GAAP”), but should not be considered as a substitute for, or superior to, GAAP results.

A reconciliation of the differences between Adjusted EBITDA and the most comparable financial measure calculated and presented in accordance with GAAP, is presented under the heading “Reconciliation of Non-GAAP Financial Information to GAAP” immediately following the Condensed Consolidated Statements of Operations included below.

The difference between Adjusted EBITDA per share, a non-GAAP measure, and GAAP EPS, is interest, income tax provision or benefit, depreciation and amortization, impairment losses, share-based compensation and other non-cash charges.

Adjusted EBITDA for the fourth quarter of 2009 was $1.7 million or $0.07 per share versus $1.1 million or $0.06 per share in the fourth quarter of 2008. For the full year, Adjusted EBITDA was $7.3 million or $0.32 per share versus $3.0 million or $0.15 per share in the prior year.

Conference Call

A conference call will be held today at 5:00 p.m. Eastern Time to review these results. Interested parties can follow the call via the Internet at ZAGG’s Investor Relations page. The call will be available for replay for 30 days by dialing 1-877-660-6853 and entering account number 286 and call ID number 346764. A podcast of the event will also be available online or via Investor Calendar’s RSS feed.

For more information about ZAGG, please visit www.ZAGG.com.

Non-GAAP Financial Disclosure:

Investors are cautioned that the Adjusted EBITDA, or earnings/(loss) before other income/(expense), taxes, depreciation and amortization, impairment losses and stock-based compensation, and adjusted net income, or net income excluding amortization of intangible assets and share-based compensation expense related to stock and stock options, information contained in this press release are not financial measures under generally accepted accounting principles. In addition, they should not be construed as alternatives to any other measures of performance determined in accordance with generally accepted accounting principles, or as indicators of our operating performance, liquidity or cash flows generated by operating, investing and financing activities, as there may be significant factors or trends that they fail to address. We present this financial information because we believe that it is helpful to some investors as a measure of our performance. We caution investors that non-GAAP financial information, by its nature, departs from traditional accounting conventions; accordingly, its use can make it difficult to compare our current results with our results from other reporting periods and with the results of other companies.